Trial Profile
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2010
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Cardiovascular disorders; Thrombosis
- Focus Pharmacokinetics
- 02 Oct 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.
- 06 Sep 2008 New trial record.